Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
semaglutide
Biotech
Novo stock crashes after CagriSema misses weight-loss goal
The next-gen obesity prospect failed to achieve the level of weight loss targeted by executives, wiping 19% off the value of the Danish drugmaker.
Nick Paul Taylor
Dec 20, 2024 8:15am
Macrocyclic peptides preserve muscle in mice given semaglutide
Dec 12, 2024 12:45pm
Biolexis enters small molecule into oral GLP-1 horse race
Sep 13, 2024 12:24pm
Terns' ex-MASH drug cuts fat, not muscle in GLP-1 combo in mice
Jun 25, 2024 8:51am
Fractyl's GLP-1 gene therapy makes weight loss last in mice
Jun 24, 2024 11:11am
A look at the R&D landscape in obesity, led by GLP-1s
Mar 19, 2024 8:00am
